Proton pump inhibitors (PPIs) are widely used though an association with hypomagnesaemia and hypocalcaemia has only been described since 2006. Patients typically present after years of stable dosing with musculoskeletal, neurological or cardiac arrhythmic symptoms, but it is likely that many cases are under-recognised. Magnesium levels resolve rapidly on discontinuation of PPI therapy and hypomagnesaemia recurs rapidly on rechallenge with any agent in the class. The cellular mechanisms of magnesium homeostasis are increasingly being understood, including both passive paracellular absorption through claudins and active transcellular transporters, including the transient receptor potential channels (TRPM6) identified in the intestine and nephron. PPIs may alter luminal pH by modulating pancreatic secretions, affecting non-gastric H+K+ATPase secretion, altering transporter transcription or channel function. A small reduction in intestinal absorption appears pivotal in causing cumulative deficiency. Risk factors have been associated to help identify patients at risk of this effect but clinical vigilance remains necessary for diagnosis.

Citations

Citations to this article as recorded by  

• Use of Acid-Suppression Therapy and Odds of Migraine and Severe Headache in the National Health and Nutrition Examination Survey
  Margaret Slavin, Cara L. Frankenfeld, Alexander B. Guirguis, Elizabeth K. Seng
  Neurology Clinical Practice.2024;[Epub]     CrossRef
• Magnesium Homeostasis
  Aubrey R. Morrison
  Clinical Journal of the American Society of Nephrology.2023; 18(7): 969.     CrossRef
• Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis
  Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Musliu Adetola Tolani, Lazaro
  Archivio Italiano di Urologia e Andrologia.2022; 94(4): 507.     CrossRef
• An overview of diagnosis and management of drug‐induced hypomagnesemia
  George Liamis, Ewout J. Hoorn, Matilda Florentin, Haralampos Milionis
  Pharmacology Research & Perspectives.2021;[Epub]     CrossRef
• Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
  Yi-Chao Shi, Shun-Tian Cai, Ya-Ping Tian, Hui-Jun Zhao, Yan-Bing Zhang, Jing Chen, Rong-Rong Ren, Xi Luo, Li-Hua Peng, Gang Sun, Yun-Sheng Yang
  Genomics, Proteomics & Bioinformatics.2019; 17(1): 52.     CrossRef
• Atrial fibrillation and gastrooesophageal reflux disease: association mechanisms, treatment approaches
  O. N. Antropova, N. V. Pyrikova, I. V. Osipova
  Russian Journal of Cardiology.2019; (7): 103.     CrossRef
• Do stop me now: gastric acid-reducing drugs following renal transplantation
  Ines Held, Rhodri Pyart
  Journal of Kidney Care.2018; 3(1): 6.     CrossRef
• Magnesium homeostasis in cattle: absorption and excretion
  Holger Martens, Sabine Leonhard-Marek, Monika Röntgen, Friederike Stumpff
  Nutrition Research Reviews.2018; 31(1): 114.     CrossRef
• A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
  Li-Yuan Yu, Lu-Ning Sun, Xue-Hui Zhang, Yue-Qi Li, Lei Yu, Zi-Qing-Yun Yuan, Ling Meng, Hong-Wen Zhang, Yong-Qing Wang
  Advances in Therapy.2017; 34(5): 1070.     CrossRef
• Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis
  Young Joo Yang, Chang Seok Bang, Gwang Ho Baik, Tae Young Park, Suk Pyo Shin, Ki Tae Suk, Dong Joon Kim
  BMC Gastroenterology.2017;[Epub]     CrossRef
• Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
  Jung Hwa Min, You Sun Kim
  Gut and Liver.2016; 10(4): 493.     CrossRef
• Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study
  Cheol Min Shin, Nayoung Kim, Yong Sung Kim, Ryoung Hee Nam, Ji Hyun Park, Dong Ho Lee, Yeong-Jae Seok, Yeon-Ran Kim, Joo-Hyon Kim, Jung Min Kim, Joo Sung Kim, Hyun Chae Jung
  Gut and Liver.2016; 10(6): 896.     CrossRef